Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan Pharmas Seek Advantages In High Hay Fever Season

This article was originally published in PharmAsia News

Executive Summary

Japanese drug makers seek to expand their lines of hay fever drugs to take advantage of a heavy season for the ailment by offering year-round offshoots. Some firms are emphasizing protection against house dust and pollen from a Japanese cypress while others seek to make over-the-counter versions of prescription drugs. The pollen count in Japan this spring is projected to be as much as 200 percent higher than last year in parts of the country. (Click here for more - a subscription may be required
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068082

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel